Literature DB >> 23054563

Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.

Kevin Petrecca1, Marie-Christine Guiot, Valerie Panet-Raymond, Luis Souhami.   

Abstract

Glioblastomas (GBM) are highly motile cancers that invade through normal brain. In the absence of curative chemotherapy this invasion, beyond surgical and radiotherapy margins, to distant brain sites is thought to be an important cause of treatment failure. Paradoxically, studies analyzing failure patterns have consistently shown that the large majority of failures occur at the original tumor site. This conflict may be explained by the fact these cancers are often only sub-totally resected and radiotherapy and chemotherapies fail to control this significant local cancer burden. We analyzed the failure pattern in 20 consecutive patients with complete resection of the gadolinium-enhancing portion of GBM demonstrated on the immediate post-operative magnetic resonance study, and who underwent a radical course of radiotherapy and chemotherapy. We found that recurrences occurred only at the resection margin in 17 of 20 patients. Recurrences were exclusively distant in 2 of 20 patients and occurred at both the resection margin and a distant site in 1 of 20 cases. We found that even in cases of complete resection of the gadolinium-enhancing portion of GBM 85 % of recurrences are localized to the resection margin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054563     DOI: 10.1007/s11060-012-0983-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

2.  New prototype neuronavigation system based on preoperative imaging and intraoperative freehand ultrasound: system description and validation.

Authors:  Laurence Mercier; Rolando F Del Maestro; Kevin Petrecca; Anna Kochanowska; Simon Drouin; Charles X B Yan; Andrew L Janke; Sean Jy-Shyang Chen; D Louis Collins
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-10-01       Impact factor: 2.924

3.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

4.  Radiographic patterns of relapse in glioblastoma.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

5.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

6.  Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.

Authors:  Benoît Pirotte; Serge Goldman; Olivier Dewitte; Nicolas Massager; David Wikler; Florence Lefranc; Nordeyn Oulad Ben Taib; Sandrine Rorive; Philippe David; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

7.  Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.

Authors:  Mark W McDonald; Hui-Kuo G Shu; Walter J Curran; Ian R Crocker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

Review 8.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

9.  A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients.

Authors:  Edward Pan; Susan B Mitchell; Jerry S Tsai
Journal:  J Neurooncol       Date:  2008-04-04       Impact factor: 4.130

10.  Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.

Authors:  Benoit J M Pirotte; Marc Levivier; Serge Goldman; Nicolas Massager; David Wikler; Olivier Dewitte; Michael Bruneau; Sandrine Rorive; Philippe David; Jacques Brotchi
Journal:  Neurosurgery       Date:  2009-03       Impact factor: 4.654

View more
  93 in total

1.  Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.

Authors:  Christoph Straube; Greeshma Elpula; Jens Gempt; Julia Gerhardt; Stefanie Bette; Claus Zimmer; Friederike Schmidt-Graf; Bernhard Meyer; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-06-14       Impact factor: 3.621

2.  Photochemical internalization-mediated nonviral gene transfection: polyamine core-shell nanoparticles as gene carrier.

Authors:  Genesis Zamora; Frederick Wang; Chung-Ho Sun; Anthony Trinidad; Young Jik Kwon; Soo Kyung Cho; Kristian Berg; Steen J Madsen; Henry Hirschberg
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

3.  Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Anna Maria Ascolese; Matteo Simonelli; Armando Santoro; Elena Clerici; Marco Rossi; Marta Scorsetti; Lorenzo Bello
Journal:  J Neurooncol       Date:  2017-07-08       Impact factor: 4.130

4.  In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The φ-Index.

Authors:  Spyridon Bakas; Hamed Akbari; Jared Pisapia; Maria Martinez-Lage; Martin Rozycki; Saima Rathore; Nadia Dahmane; Donald M O'Rourke; Christos Davatzikos
Journal:  Clin Cancer Res       Date:  2017-04-20       Impact factor: 12.531

Review 5.  Improving the accuracy of brain tumor surgery via Raman-based technology.

Authors:  Todd Hollon; Spencer Lewis; Christian W Freudiger; X Sunney Xie; Daniel A Orringer
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

6.  Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.

Authors:  Reena P Thomas; Seema Nagpal; Michael Iv; Scott G Soltys; Sophie Bertrand; Judith S Pelpola; Robyn Ball; Jaden Yang; Vandana Sundaram; Jonathan Lavezo; Donald Born; Hannes Vogel; J Martin Brown; Lawrence D Recht
Journal:  Clin Cancer Res       Date:  2019-09-19       Impact factor: 12.531

7.  Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene.

Authors:  Frederick Wang; Genesis Zamora; Chung-Ho Sun; Anthony Trinidad; Changho Chun; Young Jik Kwon; Kristian Berg; Steen J Madsen; Henry Hirschberg
Journal:  J Neurooncol       Date:  2014-03-08       Impact factor: 4.130

8.  Simultaneous In Vivo Fluorescent Markers for Perfusion, Protoporphyrin Metabolism, and EGFR Expression for Optically Guided Identification of Orthotopic Glioma.

Authors:  Jonathan T Elliott; Kayla Marra; Linton T Evans; Scott C Davis; Kimberley S Samkoe; Joachim Feldwisch; Keith D Paulsen; David W Roberts; Brian W Pogue
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

9.  Malignancy probability map as a novel imaging biomarker to predict malignancy distribution: employing MRS in GBM patients.

Authors:  Manijeh Beigi; Kevan Ghasemi; Parvin Mirzaghavami; Mohammadreza Khanmohammadi; Hamidreza SalighehRad
Journal:  J Neurooncol       Date:  2018-03-14       Impact factor: 4.130

10.  Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.

Authors:  Mehboob Ali; Kathryn Heyob; Naduparambil K Jacob; Lynette K Rogers
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.